1. Home
  2. SOR vs FBRX Comparison

SOR vs FBRX Comparison

Compare SOR & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Source Capital Inc.

SOR

Source Capital Inc.

HOLD

Current Price

$47.92

Market Cap

395.9M

Sector

Finance

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$34.69

Market Cap

367.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOR
FBRX
Founded
1968
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.9M
367.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOR
FBRX
Price
$47.92
$34.69
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$67.00
AVG Volume (30 Days)
16.2K
199.7K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
7.24%
N/A
EPS Growth
N/A
N/A
EPS
6.50
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.41
$4.90
52 Week High
$42.75
$35.46

Technical Indicators

Market Signals
Indicator
SOR
FBRX
Relative Strength Index (RSI) 58.92 67.86
Support Level $46.51 $30.50
Resistance Level $48.45 $33.58
Average True Range (ATR) 0.80 3.47
MACD 0.05 0.22
Stochastic Oscillator 90.00 95.99

Price Performance

Historical Comparison
SOR
FBRX

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Share on Social Networks: